Skip to main content

Advertisement

Log in

Alzheimer’s disease

Tangles, not TANGO: targeting tau aggregates

  • News & Views
  • Published:

From Nature Aging

View current issue Submit your manuscript

Targeting tau in addition to amyloid-β could be the next phase of disease modification in Alzheimer’s disease. The TANGO trial of gosuranemab, which binds the tau N terminus, affected neither clinical outcomes nor brain levels of aggregated tau. The results highlight the importance and challenge of reducing aggregated tau.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1: Gosuranemab was safe and tolerable, and bound tau monomers, but did not affect tau PET.

References

  1. Shulman, M. et al. Nat. Aging https://doi.org/10.1038/s43587-023-00523-w (2023).

    Article  PubMed  Google Scholar 

  2. van Dyck, C. H. et al. N. Engl. J. Med. 388, 9–21 (2022).

    Article  PubMed  Google Scholar 

  3. Sims, J. R. et al. J. Am. Med. Assoc. 330, 512–527 (2023).

    Article  CAS  Google Scholar 

  4. Serrano-Pozo, A., Frosch, M. P., Masliah, E. & Hyman, B. T. Cold Spring Harb. Perspect. Med. 1, a006189 (2011).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Sato, C. et al. Neuron 97, 1284–1298.e7 (2018).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Mengel, D. et al. Ann. Neurol. 88, 878–892 (2020).

    Article  CAS  PubMed  Google Scholar 

  7. Monteiro, C. et al. Neurology 101, e1391–e1401 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Florian, H. et al. Brain 146, 2275–2284 (2023).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Doody, R. S. et al. N. Engl. J. Med. 370, 311–321 (2014).

    Article  CAS  PubMed  Google Scholar 

  10. Sperling, R. A. et al. N. Engl. J. Med. 389, 1096–1077 (2023).

    Article  CAS  PubMed  Google Scholar 

  11. Mummery, C. J. et al. Nat. Med. 29, 1437–1447 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Fitzpatrick, A. W. P. et al. Nature 547, 185–190 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Horie, K. et al. Nat. Med. 29, 1954–1963 (2023).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ossenkoppele, R. et al. Nat. Med. 28, 2381–2387 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Therriault, J. et al. Nat. Aging 2, 526–535 (2022).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Andrew M. Stern.

Ethics declarations

Competing interests

A.M.S. receives research support from the following grants: K08 NS128329 and the Alzheimer’s Association. R.A.S. has served as a paid consultant for AC Immune, Alector, Acumen, Bristol Myers Squibb, Genentech, NervGen, Oligomerix, Prothena, Renew, Vigil Neuroscience, Ionis and Vaxxinity. She receives research support from Eisai and Eli Lilly as part of public–private partnership clinical trials, and also receives research support from the following grants: P01 AG036694, U24 AG057437, R01 AG063689, R01 AG054029, R01 AG053798, GHR Foundation, National Institute on Aging, Fidelity Biosciences, and the Alzheimer’s Association.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stern, A.M., Sperling, R.A. Tangles, not TANGO: targeting tau aggregates. Nat Aging 3, 1472–1473 (2023). https://doi.org/10.1038/s43587-023-00526-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s43587-023-00526-7

  • Springer Nature America, Inc.

Navigation